Biomarkers Market worth $45.55 Billion by 2020
The report â€œBiomarkers Market by Product (Consumables, Services), by Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine), Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020â€? report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the global biomarkers market along with the estimates and forecasts of the revenue and market share analysis. http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market43.html
The global biomarkers market will be valued at $24.10 Billion in 2015. It is expected to grow at a CAGR of 13.58% to reach $45.55 Billion by 2020. Increasing healthcare and R&D expenditure are the key growth drivers in this market. However, poorly suited regulatory & reimbursement systems, high cost of tests and sample collection & storage may hinder the growth of this market. The global biomarkers market is segmented on the basis of product, type of biomarker, application, and disease indication. On the basis of application, the market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and others. Of these, diagnostics development accounted for the largest share of the global biomarkers market in 2015. On the other hand, personalized medicine is expected to grow at the highest rate. By product, the market is divided into consumables, services, and software. Of these, consumables accounted for the largest share and are expected to show the highest growth. On the basis of type, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. On the basis of disease indications, the biomarkers market is categorized into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases. The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The major players in this market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Enzo Biochem (U.S.), EKF Diagnostics Holdings plc (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
About MarketsandMarkets MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model â€“ GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&Mâ€™s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact: MarketsandMarkets 701 Pike Street Suite 2175, Seattle, WA 98101, United States Telephone No : 1-888-600-6441 Email: firstname.lastname@example.org